MENU
TVRD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Tvardi Therapeutics (TVRD) Earnings Date & Reports
Tvardi Therapeutics Inca clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting Signal Transducer and Activator of Transcription 3 (STAT3) to treat inflammatory and proliferative diseases with unmet need... Show more
A.I. Advisor
published Earnings
TVRD is expected to report earnings to fall 3.51% to -70 cents per share on August 13
Q2'26
Est.
$-0.70
Q1'26
Missed
by $0.18
Q4'25
Missed
by $0.58
Q3'25
Missed
by $0.36
Q2'25
Missed
by $0.79
The last earnings report on May 08 showed earnings per share of -73 cents, missing the estimate of -55 cents. With 33.10K shares outstanding, the current market capitalization sits at 25.24M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information